Search

Your search keyword '"Nuria Virgili Casas"' showing total 3 results
Start Over Author "Nuria Virgili Casas" Publication Year Range Last 3 years
3 results on '"Nuria Virgili Casas"'

1. COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure

Author

Loris Pironi a, b, Denise Jezerski c, Jacek Sobocki d, Simon Lal e, Tim Vanuytsel f, Miriam Theilla g, Anna S. Sasdelli b, Cecile Chambrier h, Konrad Matysiak i, Umberto Aimasso j, Henrik H. Rasmussen k, Amelia Jukes l, Marek Kunecki m, David Seguy n, St ephane M. Schneider o, Joanne Daniels p, Florian Poullenot q, Manpreet S. Mundi r, Przemysław Matras s, Marcin Folwarski t, Adriana Crivelli u, Nicola Wyer v, Lars Ellegard w, Lidia Santarpia x, Marianna Arvanitakis y, Corrado Spaggiari z, Georg Lamprecht aa, Francesco W. Guglielmi ab, Antonella Lezo ac, Sabrina Layec ad, Esther Ramos Boluda ae, Anat Guz-Mark af, Paolo Gandullia ah, Cristina Cuerda ai, Emma Osland aj, Maria Immacolata Spagnuolo, Zeljko Krznaric al, Luisa Masconale am, Brooke Chapman an, María Maíz-Jim enez ao, Paolo Orlandoni ap, Mariana Hollanda Martins da Rocha aq, M. Nuria Virgili-Casas ar, Maryana Doitchinova-Simeonova as, Laszlo Czako at, Andr e Van Gossum au, Lorenzo D'Antiga av, Looi C. Ee aw, Daruneewan Warodomwichit ax, Marina Taus ay, Sanja Kola cek az, Ronan Thibault ba, Giovanna Verlato bb, Aurora E. Serralde-Zú~niga bc, Jos e I. Botella-Carretero bd, Pilar Serrano Aguayo be, Gabriel Olveira bf, Sirinuch Chomtho bg, Veeradej Pisprasert bi, Georgijs Moisejevs bj, Ana Zugasti Murillo bk, Ma Estrella Petrina J auregui bl, Marta Bueno Díez bm, Mohammad Shukri Jahit bn, Narumon Densupsoontorn bo, Ali Tamer bp, Giorgia Brillanti a, Francisca Joly bq, A, Loris Pironi, B, C, Denise Jezerski, D, Jacek Sobocki, E, Simon Lal, F, Tim Vanuytsel, G, Miriam Theilla, Sasdelli b, Anna S., H, Cecile Chambrier, I, Konrad Matysiak, J, Umberto Aimasso, Rasmussen k, Henrik H., L, Amelia Juke, M, Marek Kunecki, N, David Seguy, Schneider o, St ephane M., P, Joanne Daniel, Q, Florian Poullenot, Mundi r, Manpreet S., S, Przemysław Matra, T, Marcin Folwarski, U, Adriana Crivelli, V, Nicola Wyer, W, Lars Ellegard, X, Lidia Santarpia, Y, Marianna Arvanitaki, Z, Corrado Spaggiari, Lamprecht aa, Georg, Guglielmi ab, Francesco W., Lezo ac, Antonella, Layec ad, Sabrina, Ramos Boluda ae, Esther, Guz-Mark af, Anat, Ag, Gandullia ah, Paolo, Cuerda ai, Cristina, Osland aj, Emma, Spagnuolo, MARIA IMMACOLATA, Krznaric al, Zeljko, Masconale am, Luisa, Chapman an, Brooke, Maíz-Jim enez ao, María, Orlandoni ap, Paolo, Hollanda Martins da Rocha aq, Mariana, Nuria Virgili-Casas ar, M., Doitchinova-Simeonova as, Maryana, Czako at, Laszlo, e Van Gossum au, Andr, D'Antiga av, Lorenzo, Ee aw, Looi C., Warodomwichit ax, Daruneewan, Taus ay, Marina, Kola cek az, Sanja, Thibault ba, Ronan, Verlato bb, Giovanna, Serralde-Zú~niga bc, Aurora E., Botella-Carretero bd, Jos e I., Serrano Aguayo be, Pilar, Olveira bf, Gabriel, Chomtho bg, Sirinuch, Bh, Pisprasert bi, Veeradej, Moisejevs bj, Georgij, Zugasti Murillo bk, Ana, J auregui bl, Ma Estrella Petrina, Bueno Díez bm, Marta, Shukri Jahit bn, Mohammad, Densupsoontorn bo, Narumon, Tamer bp, Ali, A, Giorgia Brillanti, and Joly bq, Francisca

Published
2023

2. COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure

Author

Loris Pironi, Denise Jezerski, Jacek Sobocki, Simon Lal, Tim Vanuytsel, Miriam Theilla, Anna S. Sasdelli, Cecile Chambrier, Konrad Matysiak, Umberto Aimasso, Henrik H. Rasmussen, Amelia Jukes, Marek Kunecki, David Seguy, Stéphane M. Schneider, Joanne Daniels, Florian Poullenot, Manpreet S. Mundi, Przemysław Matras, Marcin Folwarski, Adriana Crivelli, Nicola Wyer, Lars Ellegard, Lidia Santarpia, Marianna Arvanitakis, Corrado Spaggiari, Georg Lamprecht, Francesco W. Guglielmi, Antonella Lezo, Sabrina Layec, Esther Ramos Boluda, Anat Guz-Mark, Paolo Gandullia, Cristina Cuerda, Emma Osland, Maria I. Spagnuolo, Zeljko Krznaric, Luisa Masconale, Brooke Chapman, María Maíz-Jiménez, Paolo Orlandoni, Mariana Hollanda Martins da Rocha, M. Nuria Virgili-Casas, Maryana Doitchinova-Simeonova, Laszlo Czako, Andrè Van Gossum, Lorenzo D'Antiga, Looi C. Ee, Daruneewan Warodomwichit, Marina Taus, Sanja Kolaček, Ronan Thibault, Giovanna Verlato, Aurora E. Serralde-Zúñiga, José I. Botella-Carretero, Pilar Serrano Aguayo, Gabriel Olveira, Sirinuch Chomtho, Veeradej Pisprasert, Georgijs Moisejevs, Ana Zugasti Murillo, Ma Estrella Petrina Jáuregui, Marta Bueno Díez, Mohammad Shukri Jahit, Narumon Densupsoontorn, Ali Tamer, Giorgia Brillanti, Francisca Joly, University of Bologna/Università di Bologna, Cleveland Clinic, Centre of Postgraduate Medical Education, University of Manchester [Manchester], Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Tel Aviv University (TAU), Hospices Civils de Lyon (HCL), Poznan University of Life Sciences (Uniwersytet Przyrodniczy w Poznaniu) (PULS), Città della Salute e della Scienza University-Hospital, Aalborg University [Denmark] (AAU), University Hospital of Wales (UHW), University of Lódź, CHU Lille, Centre Hospitalier Universitaire de Nice (CHU Nice), Nottingham University Hospitals NHS Trust (NUH), CHU Bordeaux [Bordeaux], Mayo Clinic and Mayo College of Medicine, Rochester, Medical University of Lublin, Medical University of Gdańsk, Hospital Universitario Fundacion Favaloro, University Hospital Coventry, Sahlgrenska Academy at University of Gothenburg [Göteborg], University of Naples Federico II = Università degli studi di Napoli Federico II, Hôpital Erasme [Bruxelles], Clinique Saint-Yves [Rennes], CHU Pontchaillou [Rennes], Nutrition, Métabolismes et Cancer (NuMeCan), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Universidad de Málaga [Málaga] = University of Málaga [Málaga], Mahidol University [Bangkok], University of Sakarya, Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), and The project of the ESPEN database for Chronic Intestinal Failure was promoted by the ESPEN Executive Committee in 2013, was approved by the ESPEN Council and was supported by an ESPEN grant.

Subjects
Home parenteral nutrition, Nutrition and Dietetics, Pandemic, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Epidemiology, SARS-CoV-2, Endocrinology, Diabetes and Metabolism, COVID-19, 03.02. Klinikai orvostan, Intestinal failure, [SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
Abstract

Background and aimsTo investigate the incidence and the severity of COVID-19 infection in patients enrolled in the database for home parenteral nutrition (HPN) for chronic intestinal failure (CIF) of the European Society for Clinical Nutrition and Metabolism (ESPEN).MethodsPeriod of observation: March 1st, 2020 March 1st, 2021. Inclusion criteria: patients included in the database since 2015 and still receiving HPN on March 1st, 2020 as well as new patients included in the database during the period of observation. Data related to the previous 12 months and recorded on March 1st 2021: 1) occurrence of COVID-19 infection since the beginning of the pandemic (yes, no, unknown); 2) infection severity (asymptomatic; mild, no-hospitalization; moderate, hospitalization no-ICU; severe, hospitalization in ICU); 3) vaccinated against COVID-19 (yes, no, unknown); 4) patient outcome on March 1st 2021: still on HPN, weaned off HPN, deceased, lost to follow up.ResultsSixty-eight centres from 23 countries included 4680 patients. Data on COVID-19 were available for 55.1% of patients. The cumulative incidence of infection was 9.6% in the total group and ranged from 0% to 21.9% in the cohorts of individual countries. Infection severity was reported as: asymptomatic 26.7%, mild 32.0%, moderate 36.0%, severe 5.3%. Vaccination status was unknown in 62.0% of patients, non-vaccinated 25.2%, vaccinated 12.8%. Patient outcome was reported as: still on HPN 78.6%, weaned off HPN 10.6%, deceased 9.7%, lost to follow up 1.1%. A higher incidence of infection (p = 0.04), greater severity of infection (p < 0.001) and a lower vaccination percentage (p = 0.01) were observed in deceased patients. In COVID-19 infected patients, deaths due to infection accounted for 42.8% of total deaths.ConclusionsIn patients on HPN for CIF, the incidence of COVID-19 infection differed greatly among countries. Although the majority of cases were reported to be asymptomatic or have mild symptoms only, COVID-19 was reported to be fatal in a significant proportion of infected patients. Lack of vaccination was associated with a higher risk of death. Background and aimsTo investigate the incidence and the severity of COVID-19 infection in patients enrolled in the database for home parenteral nutrition (HPN) for chronic intestinal failure (CIF) of the European Society for Clinical Nutrition and Metabolism (ESPEN).MethodsPeriod of observation: March 1st, 2020 March 1st, 2021. Inclusion criteria: patients included in the database since 2015 and still receiving HPN on March 1st, 2020 as well as new patients included in the database during the period of observation. Data related to the previous 12 months and recorded on March 1st 2021: 1) occurrence of COVID-19 infection since the beginning of the pandemic (yes, no, unknown); 2) infection severity (asymptomatic; mild, no-hospitalization; moderate, hospitalization no-ICU; severe, hospitalization in ICU); 3) vaccinated against COVID-19 (yes, no, unknown); 4) patient outcome on March 1st 2021: still on HPN, weaned off HPN, deceased, lost to follow up.ResultsSixty-eight centres from 23 countries included 4680 patients. Data on COVID-19 were available for 55.1% of patients. The cumulative incidence of infection was 9.6% in the total group and ranged from 0% to 21.9% in the cohorts of individual countries. Infection severity was reported as: asymptomatic 26.7%, mild 32.0%, moderate 36.0%, severe 5.3%. Vaccination status was unknown in 62.0% of patients, non-vaccinated 25.2%, vaccinated 12.8%. Patient outcome was reported as: still on HPN 78.6%, weaned off HPN 10.6%, deceased 9.7%, lost to follow up 1.1%. A higher incidence of infection (p = 0.04), greater severity of infection (p < 0.001) and a lower vaccination percentage (p = 0.01) were observed in deceased patients. In COVID-19 infected patients, deaths due to infection accounted for 42.8% of total deaths.ConclusionsIn patients on HPN for CIF, the incidence of COVID-19 infection differed greatly among countries. Although the majority of cases were reported to be asymptomatic or have mild symptoms only, COVID-19 was reported to be fatal in a significant proportion of infected patients. Lack of vaccination was associated with a higher risk of death.

Published
2023
Full Text
View/download PDF

3. [Nutrition in palliative care: guidelines from the Working Group on Bioethics, Spanish Society of Clinical Nutrition and Metabolism (SENPE)]

Author

Ana Cantón Blanco, M.ª Dolores del Olmo García, José Manuel Moreno Villares, Julia Álvarez Hernández, Isabel Ferrero López, Irene Bretón Lesmes, Nuria Virgili Casas, Rosana Ashbaugh Enguídanos, Francisca Margarita Lozano Fuster, Carmina Wanden-Berghe, José A. Irles Rocamora, Juan B. Molina Soria, and Juan Carlos Montejo González

Subjects
Societies, Scientific, Nutrition and Dietetics, Enteral Nutrition, Nutrición artificial. Directrices anticipadas. Agonía. Soporte nutricional. Enfermedad terminal, Palliative Care, Quality of Life, Medicine (miscellaneous), Humans, Bioethics
Abstract

Palliative care provides a holistic approach and care for patients with a terminal illness and their families. In palliative care physical complaints as well as emotional, social and spiritual aspects are considered. Nutritional care should be also considered within palliative support. For those working in the nutritional support field, to withhold or withdraw nutritional support may be an ethical dilemma in this scenario. The controversy starts when considering nutrition and hydration as basic care or a treatment. The goals of nutrition support in palliative care patients differ from common ones, aiming to improve quality of life, survival or both. The decision should be based on a consideration of prognosis (length of survival), quality of life, and risks-benefits ratio. Regarding oral nutrition (with or without oral supplements) the idea prevails of "comfort feeding", based on providing oral feeding till discomfort or avoidance develop. There is no evidence on the benefit of specific nutrients, despite the fact that omega-3 FAs may have some positive effects in patients with cancer. Regarding nutritional support (enteral or parenteral), no scientific evidence is present, so the decision needs to be agreed according to the desires and beliefs of the patient and their family, and based on a consensus with the interdisciplinary team on the aims of this support.Los cuidados paliativos proporcionan una atención integral que tiene en cuenta los aspectos físicos, emocionales, sociales y espirituales del paciente con enfermedad terminal y su entorno familiar. El tratamiento nutricional debe formar parte activa de los equipos de cuidados paliativos. La necesidad de iniciar o no un tratamiento nutricional sigue siendo, desde hace décadas, uno de los principales problemas éticos a los que se enfrentan los profesionales dedicados a la nutrición clínica. El origen de tal controversia radica, fundamentalmente, en cómo se consideran la nutrición y la hidratación: cuidado/soporte o tratamiento médico. Los objetivos fundamentales del tratamiento nutricional en los pacientes en cuidados paliativos deben ser otros: la mejoría de la calidad de vida, de la supervivencia o de ambas. La decisión de indicar o no el tratamiento nutricional en cuidados paliativos debe tomarse tras considerar el pronóstico, la calidad de vida y la relación “riesgo/beneficio”. En relación a la alimentación por vía oral (con o sin suplementos orales), prevalece la idea de la “alimentación de confort”, que se basa en intentos de alimentación oral hasta que se produzcan la incomodidad y/o el rechazo del paciente. No existen evidencias que justifiquen el uso de nutrientes específicos, aunque desde hace años se señala la posibilidad de lograr beneficios cuando se utilizan ácidos grasos omega-3 en los pacientes con cáncer. En cuanto al tratamiento nutricional (enteral o parenteral), en ausencia de evidencia, las decisiones sobre si iniciar una nutrición artificial en un paciente paliativo deben tomarse teniendo en cuenta los deseos y creencias del paciente y sus familiares, y basarse en el consenso del equipo interdisciplinar sobre los objetivos que se persiguen al iniciarla.

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results